Gene · 8793
Papers1,762
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,762
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Proteomics-based network pharmacology and molecular docking reveal the potential mechanisms of 5,6,7,4'-tetramethoxyflavone against HeLa cancer cells. | Heliyon | 2024 | 39449708 | PubTator, text mining | PubMed |
| Tannic acid elicits differential gene regulation in prostate cancer apoptosis. | Acta Pharm | 2024 | 39279521 | PubTator, text mining | PubMed |
| TNFRSF10D expression as a potential biomarker for cisplatin-induced damage and ovarian tumor relapse prediction. | Pathol Res Pract | 2024 | 39255671 | PubTator, text mining | PubMed |
| Apoptotic Receptors and CD107a Expression by NK Cells in an Interaction Model with Trophoblast Cells. | Curr Issues Mol Biol | 2024 | 39194745 | PubTator, text mining | PubMed |
| The speed of completion of the decremental responses on repetitive nerve stimulation. | Clin Neurophysiol Pract | 2024 | 39113924 | PubTator, text mining | PubMed |
| ELF3 plays an important role in defining TRAIL sensitivity in breast cancer by modulating the expression of decoy receptor 2 (DCR2). | Mol Biol Rep | 2024 | 38787503 | PubTator, text mining | PubMed |
| Unveiling heterogeneity in MSCs: exploring marker-based strategies for defining MSC subpopulations. | J Transl Med | 2024 | 38750573 | PubTator, text mining | PubMed |
| Exploring novel protein biomarkers for early-stage diagnosis and prognosis of T-acute lymphoblastic leukemia (T-ALL). | Hematol Transfus Cell Ther | 2024 | 38584071 | PubTator, text mining | PubMed |
| Interferon-β Overexpression in Adipose Tissue-Derived Stem Cells Induces HepG2 and Macrophage Cell Death in Liver Tumor Organoids via Induction of TNF-Related Apoptosis-Inducing Ligand Expression. | Int J Mol Sci | 2024 | 38279326 | PubTator, text mining | PubMed |
| Immune Escape Strategies in Head and Neck Cancer: Evade, Resist, Inhibit, Recruit. | Cancers (Basel) | 2024 | 38254801 | PubTator, text mining | PubMed |
| The Identification of New c-FLIP Inhibitors for Restoring Apoptosis in TRAIL-Resistant Cancer Cells. | Curr Issues Mol Biol | 2024 | 38248348 | PubTator, text mining | PubMed |
| Semilicoisoflavone B induces oral cancer cell apoptosis by targeting claspin and ATR-Chk1 signaling pathways. | Environ Toxicol | 2024 | 38197544 | PubTator, text mining | PubMed |
| Distinguishing features of depression in dementia from primary psychiatric disease. | Discov Ment Health | 2024 | 38175420 | PubTator, text mining | PubMed |
| CD317+ MSCs expanded with chemically defined media have enhanced immunological anti-inflammatory activities. | Stem Cell Res Ther | 2024 | 38169422 | PubTator, text mining | PubMed |
| Exploring the Potential of Rosemary Derived Compounds (Rosmarinic and Carnosic Acids) as Cancer Therapeutics: Current Knowledge and Future Perspectives. | Biomol Ther (Seoul) | 2024 | 38148552 | PubTator, text mining | PubMed |
| Hellebrigenin induces oral cancer cell apoptosis by modulating MAPK signalling and XIAP expression. | J Cell Mol Med | 2024 | 38044583 | PubTator, text mining | PubMed |
| Intrinsic factors driving mosquito vector competence and viral evolution: a review. | Front Cell Infect Microbiol | 2023 | 38188633 | PubTator, text mining | PubMed |
| [Research Progress in Stress-Induced Senescence of Renal Tubular Cells in Diabetic Nephropathy]. | Sichuan Da Xue Xue Bao Yi Xue Ban | 2023 | 38162078 | PubTator, text mining | PubMed |
| Methylation and transcriptomic expression profiles of HUVEC in the oxygen and glucose deprivation model and its clinical implications in AMI patients. | Front Genet | 2023 | 38145212 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing analysis of lung cells in COVID-19 patients with diabetes, hypertension, and comorbid diabetes-hypertension. | Front Endocrinol (Lausanne) | 2023 | 38144556 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8793/papers?page=2